DTB Letter Deplores Axing Of Diabetes Product Used By Thousands

DRUG AND THERAPEUTICS BULLETIN DTB letter deplores axing of diabetes product used by thousands A letter from the Drug and Therapeutics Bulletin, published in today’s Daily Telegraph, deplores the axing by Novo Nordisk of an insulin product, currently used by an estimated 90,000 diabetics in the UK…
Diabetes News From Medical News Today

You can leave a response, or trackback from your own site.

Leave a Reply

Copyright 2010 DiabetesSigns.org, Inc. All rights reserved. The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments. See the Terms of Service for more information. Privacy Policy

Powered by Yahoo! Answers